P2RX7 and Alzheimer disease: In this study, we investigated whether two proteins whose expression is increased in the brains of AD patients, the purinergic receptor P2X7R and the ectoenzyme TNAP [17,18,22,23], are also altered in the plasma of these patients and therefore could potentially be used as plasma biomarkers to predict the evolution of the disease.